Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors show promise in treating difficult skin diseases.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

Dupilumab may worsen hair loss in patients with alopecia areata.

The mouse models are effective for testing new hair loss treatments.

The patient's scalp lesions stabilized with a combination of treatments after initial therapies failed.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Mouse models help understand alopecia areata and find treatments.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

SLE is more common among Nigerians than previously thought, especially in women, requiring early treatment.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Early diagnosis and treatment of calcinosis cutis in lupus patients is crucial due to its rarity and potential complications.

Switching from infliximab to Ustekinumab improved both hair loss and Crohn's symptoms in the patient.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

A woman with lupus had blood cell destruction, treated successfully with medication.

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

Erythema multiforme-like lesions can occur in lupus without drug use or herpes infection.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Females are more prone to lupus and arthritis due to X chromosome factors.